Lumos Pharma Inc. (LUMO)

Business: Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases.

IPO Date: 11-Nov-2011

CEO & Chairman: Mr. Richard J. Hawkins

Chief Scientific Officer & Pres: Dr. John C. McKew Ph.D.

Listing: NASDAQ: LUMO

Country: United States

Headquarters: Austin, TX

Website: https://www.lumos-pharma.com

Market cap: $64.36 Mln

Revenue (TTM): $0.11 Mln

Earnings (TTM): $-29.52 Mln

Cash: $86.76 Mln

Total Debt: $0.48 Mln

Insider's Holding: 33.46%

Liquidity: Low

52 Week range: $6.15 - 11.52

Shares outstanding: 8,369,230

10 Years Aggregate:

• CFO: $-196.33 Mln
• EBITDA: $-245.46 Mln
• Net Profit: $-251.41 Mln